Neuphoria Therapeutics Q4'26 EPS estimate seen at (0.56) USD
Neuphoria Therapeutics is set to announce Q4'26 results on September 02, with results expected at 8:00 AM ET. Q4'26 revenue estimate is 0 USD, and EPS is anticipated at (0.56) USD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.